Drug Use

Drug policy continues to fixate on symptoms rather than the actual disease

While most Americans enjoy access to marijuana, barriers to research and knowledge expansion persist—with dangerous consequences. Unlimited research access is needed

Although studies are still mixed and products are often inconsistent, many scientists have hope that cannabidiol can help furry patients with arthritis, allergies and anxiety

New research into weed reveals how a lemon-scented terpene can ease anxiety without reducing the high.

Marijuana’s health impacts—good and bad—are coming into focus

People struggling with addiction cite untreated withdrawal, pain, discrimination and stringent policies as reasons for leaving hospitals against medical advice. We need to take their complaints seriously

Tianeptine, an addictive drug at high doses, is being sold as a dietary supplement in gas stations and convenient stores. But such products could be contaminated with metals, microorganisms or other undisclosed drugs

Levels of opioids and other drugs in sewage could help public health authorities home in on drug use and target treatment efforts

Ten years after cannabis was first legalized for recreational use in adults, scientists are struggling to provide evidence-based recommendations about the risks to young people

Most hospitals typically test people for drugs that drove overdoses 15 to 20 years ago. We need a national system for expanded testing to help patients get the treatment they need today

A recent examination of Vivitrol’s clinical trial data uncovered many hidden overdoses. Its preferential use in the criminal justice system must stop

More than 100,000 Americans die every year from drug overdoses. We should warn people in real time about dangerous adulterants in the illicit drug market